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Abstract
Background: Numerous immune-mediated diseases have been associated with the class I and II HLA genes
located within the major histocompatibility complex (MHC) consisting of highly polymorphic alleles encoded by
the HLA-A, -B, -C, -DRB1, -DQB1 and -DPB1 loci. Genotyping for HLA alleles is complex and relatively expensive.
Recent studies have demonstrated the feasibility of predicting HLA alleles, using MHC SNPs inside and outside of
HLA that are typically included in SNP arrays and are commonly available in genome-wide association studies
(GWAS). We have recently described a novel method that is complementary to the previous methods, for
accurately predicting HLA alleles using unphased flanking SNPs genotypes. In this manuscript, we address several
practical issues relevant to the application of this methodology.
Results: Applying this new methodology to three large independent study cohorts, we have evaluated the
performance of the predictive models in ethnically diverse populations. Specifically, we have found that utilizing
imputed in addition to genotyped SNPs generally yields comparable if not better performance in prediction
accuracies. Our evaluation also supports the idea that predictive models trained on one population are transferable
to other populations of the same ethnicity. Further, when the training set includes multi-ethnic populations, the
resulting models are reliable and perform well for the same subpopulations across all HLA genes. In contrast, the
predictive models built from single ethnic populations have superior performance within the same ethnic
population, but are not likely to perform well in other ethnic populations.
Conclusions: The empirical explorations reported here provide further evidence in support of the application of
this approach for predicting HLA alleles with GWAS-derived SNP data. Utilizing all available samples, we have built
“state of the art” predictive models for HLA-A, -B, -C, -DRB1, -DQB1 and -DPB1. The HLA allele predictive models,
along with the program used to carry out the prediction, are available on our website.
Background
The genes encoding the human leukocyte antigens,
HLA-A, -B, -C, -DRB1, -DQB1 and -DPB1, located
within the major histocompatibility complex (MHC),
play critical roles in immunity and host defense, risk of
autoimmune disease and cancer [1-4]. HLA also plays
an important role in organ and cellular transplantation
where mismatched HLA can lead to graft rejection and
graft-versus-host disease [5,6]. HLA genes are among
the most polymorphic systems in the human genome.
Due to the complex and redundant nature of the
sequence variations that distinguish class I (HLA-A, -B,
-C) and class II (HLA-DRB1, -DQB1 and -DPB1) alleles,
which are located within 2 to 3 hypervariable regions in
the class I (exon 2 and 3) and class II (exon 2) genes,
and the ambiguities inherent in analyzing unphased
sequences from heterozygous individuals, high resolu-
tion HLA genotyping remains labor intensive and costly.
Recently, developments in SNP genotyping have enabled
many large-scale genome-wide association studies
(GWAS) that have generated genotype data for thou-
s a n d so fS N P si nt h eM H Cr e g i o n .I th a sb e e nd e m o n -
strated that the MHC SNPS can be used to predict
HLA alleles [7,8]. Building upon the success of these
early works, we have developed a complementary
method that builds predictive models for HLA alleles
based on available unphased MHC SNP datasets
obtained from unrelated individuals whose HLA alleles
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mework of all HLA and SNP genotypes in the sample,
systematically identifies the most informative SNPs, and
has succeeded in incorporating predictive models cap-
able of a very high rate of accuracy sufficient for dedu-
cing HLA alleles in disease association GWAS datasets.
To optimize the practical value of these HLA predic-
tive models, one needs to address the following ques-
tions: (1) can imputation of untyped MHC SNPs
improve the accuracy and robustness of the model; (2)
can MHC SNPs generated by different platforms yield
comparable HLA allele predictions; (3) are prediction
models transferable across different study populations;
and (4) should multi-ethnic groups be included in the
training set when building predictive models? In this
manuscript, we explore these questions and make prac-
tical recommendations based on empirical data. Finally,
we have integrated all available data resources and pro-
duced a set of models for predicting HLA-A, -B, -C,
-DRB1, -DQB1 and -DPB1alleles.
Methods
Study populations
We utilized readily available SNP genotype data from a
cohort of normal donors who participated in a GWAS
at the Fred Hutchinson Cancer Research Center
(FHCRC), control samples from the British 1958 Birth
cohort in Welcome Trust Case Control Consortium
(WTCCC), and participants in Phase IIb clinical trial on
HIV1-vaccine (STEP). Characteristics of these cohorts
are summarized in Table 1.
FHCRC
This cohort consists of ~1,500 normal donors who were
genotyped on the Affymetrix 5.0 Human SNP Array,
and also genotyped for HLA-A, -B, -C, -DRB1 and
-DQB1 alleles. A systematic quality control (QC) has
been performed: to ensure genotyping quality, the study
genotyped 152 duplicate samples, allowing us to assess
genotype concordances. Based upon our duplicate sam-
ples, the Affymetrix-defined QC call rate threshold was
raised from 86% to 90%, to ensure that the genome-
wide genotype concordance exceeded 99%. Further, we
have ruled out any unintended sample duplication by
computing identity-by-state between all pairs of samples.
Furthermore, we have also inferred gender using SNPs,
and computed their concordance with the recorded gen-
der. Finally, a series of usual QC matrices (missing data
percentages, minor allelic frequencies and departure
from Hardy-Weinberg equilibrium) are computed and
used to filter undesirable SNPs.
WTCCC
As part of the WTCCC study, ~3,000 controls from the
British 1958 Birth cohort were genotyped on both the
Affymetrix 6.0 and Illumina 1.2M chips. About half of
these samples were also genotyped on the Affymetrix
500K chip and Illumina 550K chip in WTCCC1 studies
[10]. All samples are of Caucasian descent, and all were
genotyped for HLA-A, -B, -C, -DRB1 and -DQB1 alleles.
STEP
A Phase IIb HIV-1 vaccine clinical trial referred to as
the Step Study consisting of ~3,000 samples from sev-
eral different countries [11]. Among participants, 832
participants were genotyped on Illumina 1.2M, and were
genotyped for HLA-A, -B, -C, -DRB1 and -DPB1 alleles.
A notable feature of this group is that approximately
25% of participants are Mestizos of European and
American Indian ancestry. Following the same QC pro-
tocol described above, we computed the usual QC
metrics, and filtered out undesirable SNPs accordingly.
In addition to the SNP genotyping quality control ori-
ginally performed by each study group, we censored by
filtering SNPs with minor allele frequency less than
Table 1 Characteristics of the three study cohorts
FHCRC WTCCC* STEP
Caucasian 1280 2730 411
Mestizo/Mestiza 212
Ethnicity Others (African, Asian and other ethnic groups) 226 209
HLA-A, -B, and -C 1483 1929,1812,1558 832
HLA Loci HLA-DRB1 1481 1969 832
HLA-DQB1 1434 1965
HLA-DPB1 832
Affy 5.0 array 1506
SNP genotyping platforms Affy 500K 1480
Affy 6.0 array 2706
Illumina 550K 1438
Illumina 1.2M 2692 832
* In the WTCCC cohort, dubious samples were excluded according to WTCCC suggestions.
Number of samples in each study cohort that were of each ethnicity, genotyped for each HLA loci and genotyped on each SNP genotyping platform.
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SNPs which deviated from Hardy-Weinberg equilibrium
with p value less than 1e
-20. All HLA alleles were geno-
typed using high quality sequencing methods as dis-
cussed below.
A Brief Introduction to the HLA Prediction Methodology
A general methodology of building predictive models for
polymorphic genes using SNPs has been detailed else-
where [9]. Briefly, this methodology includes a training
procedure to produce one predictive model for each
HLA locus, and a separate procedure to validate the
predictive model. During the training process, a set of
SNPs are selected to best predict HLA alleles. The selec-
tion is carried out by using the forward-and-backward
scheme, which starts with the SNPs within a HLA gene
(if available) and gradually extends to flanking regions of
each HLA gene. The search region is empirically chosen
to maximize the prediction accuracies while retaining
parsimony. The selection process is evaluated by an
objective function, which is the negative log-likelihood
of the HLA allele given SNP genotypes penalized by the
number of haplotype parameters to be estimated.
The predictive model is validated with an independent
set of samples whose MHC SNPs and HLA alleles are
known. Given the SNP genotypes, probabilities of all
possible pairs of HLA alleles are assigned according to
the predictive model. The pair with the maximum prob-
ability is predicted to be the HLA allele for that sample,
if the probability exceeds a pre-specified confidence
threshold (CT). Typically, CT is set at 0, which means
that all samples will be predicted, i.e. the call rate is
100%. If CT is chosen to be any value greater than 0,
such as CT = 0.5 or 0.9, only the samples with the max-
imum predictive probability exceeding CT will be
assigned an HLA allele specificity. In this manuscript,
we will only list the results of call rate if CT > 0. The
accuracy of prediction is estimated by comparing pre-
dicted HLA alleles with the known HLA genotype.
The training set consisted of 630 healthy unrelated
individuals in the FHCRC cohort and the predictive
models were validated with a separate set of 630 healthy
unrelated individuals in the FHCRC cohort. The predic-
tive models achieved accuracies for HLA alleles defined
at intermediate resolution (2 digit) or high resolution (4
digit) ranging as high as 97% and 95% for HLA-A, 96%
and 93% for HLA-B, 98% and 97% for HLA-C, 93% and
79% for HLA-DRB1 and 97% and 83% for HLA-DQB1
with CT = 0.
HLA Allelic Calls in Three Cohorts
For the FHCRC cohort, HLA genotyping was initially
performed using sequence specific oligonucleotide
probes (Dynal RELITM SSO - HLA Class I & II Strips
Line strips; and the Luminex-based by One Lambda
LABType
® SSO) followed by sequencing of exon 2 and
3 for the class I HLA-A, B and C genes, and sequencing
of exon 2 for the class II HLA-DRB1 and DQB1 genes.
The same sequencing technology was used to genotype
HLA-A, -B, -C, -DRB1 and -DPB1 for the STEP. HLA-
A, -B, -C, -DRB1 and -DQB1 genotyping for the
WTCCC cohort was done using SSOP reagents from
Invitrogen. WTCCC investigators have resolved ambigu-
ous allele calls to the level of a series of alternate alleles
(Additional file 1: Table S1a) as explained on their web-
site (https://www-gene.cimr.cam.ac.uk/todd/public_data/
HLA/HLA.shtml).
Having demonstrated the high prediction accuracy of
our HLA allele prediction models in [9], we addressed
relevant practical issues for optimizing this methodol-
ogy. In order to answer the questions raised in the
Background Section, the HLA nomenclature used for
the three cohorts has to be adjusted to compensate for
the differences in the coding of ambiguous allele calls
across the three cohorts without distorting HLA allele
integrity (Additional file 1: Table S1b). As expected,
these ambiguous sets of HLA alleles represent a source
of reduced prediction accuracies, regardless of predictive
methodologies. Samples with missing HLA genotypes or
unresolved ambiguities were excluded from the analysis.
Imputation
We used IMPUTE v2 (https://mathgen.stats.ox.ac.uk/
impute/impute.html) to impute missing SNPs from the
HapMap project. Default parameters were applied to
impute only SNPs in the extended MHC region of chro-
mosome 6 (28,799,220-34,204,868) [12]. Our study sam-
ples included individuals from several ethnically distinct
p o p u l a t i o n st h a ta r en o tr e p r e s e n t e di nt h eH a p M a p
panel. For these minority populations, combining the
reference groups in the HapMap is usually preferred as
previously demonstrated [13,14]. Li et. al. [13] also
showed that even when the ethnicity-specific panel is
preferred, the error rate for using the combined refer-
ence panel increases by only 0.15%. Therefore, for data
consistency and optimal imputation performance in all
ethnic groups, we chose to use genotype data from Hap-
Map release 22 with three ethnic groups (Caucasian,
African and Asian) as the imputation reference panel.
For each imputed SNP, the genotype was called if its
posterior probability exceeds 0.8. The imputed SNPs
were then further filtered if their call rate is less than
95% or if the minor allele frequency is <1%.
Usefulness of Imputed SNPs
SNP imputation has become a routine practice in gen-
ome-wide association studies. Frequently used as the
imputation reference panel, the HapMap data (http://
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Page 3 of 13hapmap.org) includes ~2.4 million SNPs on the whole
human genome and 10,600 SNPs in the MHC region,
where typical commercial genotyping arrays have only
~2,000 SNPs. Increasing the number of SNPs used in
predicting HLA alleles may increase accuracy. In addi-
tion, a common set of HapMap SNPs, independent of
genotyping array technologies, would allow us to build
general predictive models independent of genotyping
technologies. However, this option has potential limita-
tions. First, the use of imputed SNPs may not provide
independent information, since SNPs are imputed based
on the local linkage-disequilibrium (LD) information,
which has already been incorporated via tagging SNPs
selected on commercial arrays. Further, prediction
accuracies of less common haplotypes may be negatively
impacted by restricting haplotype polymorphisms to
those within the HapMap samples.
Hence, to evaluate the utility of imputed SNPs in
building predictive models, we have empirically investi-
gated its pros and cons. In this empirical evaluation, we
used SNP genotype data from 1,260 Caucasian samples
from the FHCRC cohort which were genotyped on the
Affy 5.0 array, and used half of the samples as the train-
ing set and the other half as the validation set. To retain
the data independence, we performed imputations for
the training set and the validation set separately. For
each of the HLA-A, -B, -C, -DRB1 and -DQB1 loci, we
trained and validated the HLA predictive model using
the set of observed SNPs only, and then using the set
with both observed and imputed HapMap SNPs. To
compare the two sets of models trained with or without
imputed SNPs, we introduce a summary statistics as the
average difference in prediction accuracies among the
five HLA loci between these two sets of models. The
performance of prediction is evaluated at both inter-
mediate and high resolution using CT = 0, 0.5, and 0.9.
Recognizing that the Affy 5.0 array having the least
number of SNPs in the MHC region (Table 2) could be
a special case, we repeated the above experiment proto-
col to assess the usefulness of imputed SNPs when
SNPs were genotyped on Affy 500K, Affy 6.0 array, Illu-
mina 550K, and Illumina 1.2M, using the WTCCC con-
trol data. In this exercise, we used 1,001 samples that
were genotyped on all four technologies, per WTCCC
suggestion, and that had complete genotypes on HLA-
A, -B, and -C alleles. Randomly dividing 1,001 samples
into training and validation sets, and using genotypes
from each array technology, we repeated the same train-
ing and validation calculations using observed SNPs
only, as well as using both observed and imputed Hap-
Map SNPs.
Different Technologies
Genome-wide DNA array genotyping technologies are
rapidly converging to the Affymetrix and Illumina tech-
nologies, each of which has gone through several differ-
ent array formats, e.g., Affy 500K and 6.0, and Illumina
550K and 1.2M. Different sets of SNPs are placed on
these arrays, and the overlap between each pair of tech-
nological platforms is quite small (Table 2). To facilitate
the comparison of HLA predictive models built using
SNPs of different technologies, we performed imputa-
tion on the datasets generated by each technology to
obtain genotypes of the common set of SNPs used in
the HapMap project. With the common set of SNPs, we
can address two questions: are genotypes comparable
between technologies; and are prediction accuracies
comparable between the predictive models built using
the genotypes from different technologies?
To address these questions, we used the same set of
1,001 Caucasian samples from the WTCCC cohort
which were genotyped on four different technologies.
These samples were divided into training and validation
sets. To assess the concordance of genotype data
between technologies, we computed the Cohen’s kappa
coefficient, a commonly used index to quantify agree-
ment between two measurements [15]. It takes into
account the concordance by chance and is calculated as
 =[ P r ( a)- P r ( e)]/[1-Pr(e)], where Pr(a) is the observed
agreement percentage, and Pr(e) is the chance agree-
ment percentage. The larger the kappa coefficient, the
better the concordance is between two measurements,
with  approaching 1 as the perfect agreement. Other-
wise, the kappa coefficient approaches zero. For each
pair of technologies, we assessed the concordance
between all genotypes of SNPs that are observed in
both, SNPs that are observed in one but imputed in the
other, SNPs that are imputed in both, and the overall
HapMap SNPs. Any SNPs which were missing on one
of the paired platforms were excluded.
To address the second question, we built predictive
models on the training set using the HapMap SNPs
observed or imputed from each genotyping technology.
Then, we compared their accuracies of prediction on
Table 2 Numbers of overlapping SNPs between HapMap
project and four genotyping platforms in the extended
MHC region
1
HapMap Affy
500K
Affy
6.0
Illumina
550K
Illumina
1.2M
HapMap 10600 1307 1979 1762 4382
Affy 500K 1422 1363 272 610
Affy 6.0 2325 459 988
Illumina
550K
1944 1885
Illumina
1.2M
6303
1 The range of extended MHC region is chr6: 28,799,220 - 34,204,868 [12].
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otyping technologies at both intermediate and high reso-
lution for each HLA locus.
Across Populations
Besides the technological heterogeneity, another issue is
whether the predictive models are transferable across
different study populations of the same ethnic group,
say, the FHCRC and WTCCC populations of Caucasian
descent. To address this question, we built predictive
models using both imputed and observed HapMap
SNPs of all Caucasian samples in the FHCRC cohort,
and tested these predictive models in the WTCCC
c o h o r t .V i c ev e r s a ,w ea l s ot e s t e dW T C C Cp r e d i c t i v e
models on the Caucasian samples of the FHCRC cohort.
To minimize the possible impact of different SNP geno-
typing platforms, we used the subset of samples in the
WTCCC cohort that were genotyped on the Affy 500K
array, which is comparable to the Affy 5.0 array used in
the FHCRC cohort.
Building Models Using Multi-Ethnic Samples
HLA alleles and their allelic distributions are known to
differ substantially between ethnic groups, reflecting
their recent evolutionary histories. One natural question
is if one should develop ethnic-specific predictive mod-
els as opposed to combining all available ethnic groups
together to develop “global predictive models”.T o
address this question, we used the samples from STEP,
which includes 411 Caucasian s ,2 1 2M e s t i z o s ,a n d2 0 9
samples of other ethnicities (including 82 African, 76
Hispanic, and 51 others). We combined three sets of
150 randomly selected samples from each ethnic group
to form a training set, and built HLA predictive models
f o re a c ho ft h eH L A - A ,- B ,- C ,- D R B 1 ,a n d- D P B 1
alleles. Similarly, we also built predictive models using
only the 411 Caucasian samples. Both sets of predictive
models were validated on the samples genotyped on
Illumina 1.2M in the WTCCC study, and the remaining
samples from STEP that were not included in the train-
ing set.
Results
Imputed SNPs
To evaluate the usefulness of imputed SNPs in con-
structing HLA predictive models, we first used the SNP
data from the FHCRC cohort that was generated by the
Affy 5.0 array. Table 3 shows accuracy estimates
obtained from the validation analysis of predictive mod-
els built with and without imputed SNPs. For the pre-
dictive models built without including imputed SNPs,
the accuracies are consistent to those reported earlier
[9], and are slightly higher for high resolution HLA-
DRB1 and -DQB1 due to the consolidation of high reso-
lution alleles of the three cohorts. Of these models, the
accuracy is highest at HLA-C loci, where 98% of the
HLA alleles at intermediate resolution, and 97% at low
resolution are predicted correctly with CT = 0. By
applying a confidence threshold (CT) of 0.9 to the pos-
terior probability of HLA alleles, the highest accuracy is
increased to 99% at HLA-A loci at intermediate resolu-
tion with call rate 87%. When comparing accuracies
between predictive models built with and without
imputed SNPs, one observes that accuracies of models
with imputed SNPs are the same or higher than those
without imputed SNPs, with one exception: accuracy for
HLA-DQB1 at intermediate resolution with CT = 0.9
equals 97% with imputed SNPs (call rate 94%), versus
98% without imputed SNPs (call rate 95%). On average,
using imputed SNPs improves the prediction accuracy
(call rate) by 0.8%, 0.6%(0.4%), and 0.2%(0.6%) at inter-
mediate resolution and 1.6%, 1%(2%), and 0.6%(1%) at
Table 3 Comparison of prediction accuracies for HLA predictive models built with and without imputed SNPs
Without Imputed SNPs With Imputed SNPs
HLA- CT = 0 CT = 0.5 CT = 0.9 CT = 0 CT = 0.5 CT = 0.9
Intermediate Resolution A 97 97(100)* 99(87) 98 98(100) 99(89)
B 95 95(99) 98(86) 96 96(100) 98(88)
C 98 98(100) 98(97) 99 99(99) 99(97)
DRB1 93 93(99) 97(78) 93 93(100) 98(78)
DQB1 96 97(99) 98(95) 97 97(100) 97(94)
High Resolution A 95 95(100) 97(86) 97 97(100) 98(86)
B 93 93(98) 96(78) 93 94(97) 96(72)
C 97 97(99) 98(95) 98 98(100) 98(93)
DRB1 83 87(85) 94(48) 87 88(95) 95(59)
DQB1 94 95(100) 95(94) 95 95(100) 96(96)
* Prediction accuracy % (call rate %)
Using the Caucasian samples genotyped on the Affy 5.0 array in the FHCRC cohort, the accuracies of the predictive models built with the training set (N = 633)
were
evaluated on the validation set (N = 627) for HLA-A, -B, -C, -DRB1 and -DQB1 at intermediate and high resolution, with CT = 0, 0.5 and 0.9.
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general, this empirical result supports the hypothesis
that predictive models built with imputed SNPs would
perform equally well, if not better, in comparison with
models built without imputed SNPs.
To extend this observation beyond Affy 5.0, we used
the WTCCC data, to evaluate the usefulness of imputed
SNPs from Affy 500K, Affy 6.0, Illumina 550K, and Illu-
mina 1.2M. Figure 1 has four panels of figures, labeled
by the corresponding technologies. Comparing accura-
cies between models built with and without imputed
SNPs, one would conclude that predictive models built
with imputed SNPs again have either comparable or
better accuracies, with few exceptions. For those excep-
tions, losses of accuracies are less than 1%. Certainly,
variations between two classes of models are much less
than those between intermediate and high resolutions.
Details in accuracies of prediction across different CTs
are listed in the Additional file 1: Table S3.
Across Technologies
Realizing that there are multiple genotyping technolo-
gies, one cannot help but wonder whether using a parti-
cular genotyping technology would lead to the desired
HLA allele predictions. To address this question, we
first assess if genotype data from different technologies
are comparable. Table 4 lists kappa coefficients between
paired technologies, with respect to directly measured
genotypes and imputed genotypes. Comparing two Affy-
metrix arrays, one observes that the kappa coefficient is
as high as 99.69% for genotypes observed on both
arrays, which demonstrates high genotyping quality. The
Figure 1 Comparison of prediction accuracies between models built with and without imputed SNPs from four arrays.H a l fo ft h e
common set of samples genotyped on Affy 500K, Affy 6.0, Illumina 550K, Illumina 1.2M arrays in the WTCCC cohort were used as the training
set (N = 501) and the other half were used as the validation set (N = 500). Each panel shows a comparison of prediction accuracies for the
validation set, with models built using only SNPs observed from the array or using HapMap SNPs observed and imputed from the array. The
confidence threshold was set at CT = 0.
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500K and Observed on Affy 6.0) is 98.60%, which is the
lowest among all four comparisons. This level of con-
cordance is nevertheless quite remarkable, because it
shows high imputation quality even though nearly
10,000 SNPs are imputed on Affy 500K in this 6 Mb
region. Concordance of SNPs imputed on both plat-
forms is nearly 99.78%, partially reflecting the shared
reference panel used in the imputations. Similar concor-
dance is observed for two Illumina arrays. Across two
commercial platforms, concordance between Affy 6.0
and Illumina 1.2M is high, and equals 99.70%, 99.47%,
99.13% and 99.76% for O-O, O-I, I-O and I-I,
respectively. In general, concordance between paired
technologies is outstanding and ranges from 99.31% to
99.77%.
Now let us examine the prediction performance across
technologies. Figure 2 shows accuracies of prediction (in
percentage) in the WTCCC cohort with and without
imputed SNPs for both intermediate and high HLA
resolution predictions with CT = 0. Five HLA loci are
listed on x-axis, in the order of their chromosome posi-
tions, while four genotyping technologies are listed on
the y-axis. As the color bar shows, the red corresponds
to higher accuracy, while the dark blue shows lower
accuracy. In general, the prediction accuracies are com-
parable and are above 90%. Among the four genotyping
technologies compared, Illumina 1.2M generally per-
forms better for HLA prediction, partly due to having
the densest SNPs in the MHC region. However, when
building models using only the observed SNPs, Illumina
550K predicts up to 1% more accurately at HLA-A, and
high resolution HLA-DRB1 than Illumina 1.2M. By lim-
iting the SNPs from Illumina 1.2M to those also geno-
typed on Illumina 550K, the prediction accuracies are
inferior to the models using all SNPs from Illumina
1.2M (not shown). The slight improvement of Illumina
550K might be attributed to the different SNP contents
between the two technologies. For each HLA locus, the
variation between different technologies for the two
resolution panels with only the observed SNPs is at
With  
imputed SNPs 
Without 
imputed SNPs 
a: Affy 500K;  
b: Affy 6.0;  
c: Illumina 550K;  
d: Illumina 1.2M  
Figure 2 Comparison of genotyping arrays, with respect to their prediction accuracies. The training and validation sets were the same as
those in Figure 1. Each panel shows a comparison of prediction accuracies of models built with and without imputed SNPs from four
genotyping arrays at intermediate and high HLA resolution. The confidence threshold was set at CT = 0.
Table 4 Kappa coefficients of observed or imputed SNP
genotypes between genotyping platforms using the
WTCCC cohort data
Platform Pair O-O
* O-I
+ I-O I-I Overall
#
Affy 500K & Affy 6.0 0.9969 0.9901 0.9860 0.9978 0.9968
Illumina 550K & Illumina
1.2M
0.9996 0.9945 0.9943 0.9988 0.9977
Affy 6.0 & Illumina 1.2M 0.9970 0.9947 0.9913 0.9976 0.9955
Affy 500K & Illumina 550K 0.9976 0.9942 0.9847 0.9959 0.9942
Affy 500K & Illumina 1.2M 0.9962 0.9956 0.9876 0.9954 0.9931
Illumina 550K & Affy 6.0 0.9979 0.9897 0.9934 0.9978 0.9962
* O stands for observed genotypes of HapMap SNPs;
+ I stands for imputed genotypes using IMPUTE v2 with HapMap reference
panel of Caucasian, African and Asian.
# Overall stands for observed/imputed genotypes of HapMap SNPs;
Zhang et al. BMC Genetics 2011, 12:39
http://www.biomedcentral.com/1471-2156/12/39
Page 7 of 13most 3%. The variation decreases to 2% if imputed SNPs
were incorporated in the predictive models. This is not
surprising, given that each technology genotyped a dif-
ferent set of SNPs. Using the uniform set of HapMap
SNPs minimizes the discrepancy between technologies,
and enables one to combine data from different technol-
ogies or to use training and validation sets from differ-
ent technologies.
Results for assessing the performance of predictive
models, trained using genotypes observed and imputed
from one platform but applied to genotype data
observed and imputed from another platform, are
shown in Figure 3, which has five panels corresponding
to five HLA genes. Within each panel, we show HLA
prediction accuracies validated on four technologies (x-
axis), when the corresponding model is trained on each
of four different data sets (y-axis). The diagonal line
shows prediction accuracies when training and valida-
tion sets are genotyped on the same technology. As the
colored bar shows, red color indicates higher accuracy
and yellow color indicates relatively lower accuracy.
From visual inspection, when training and validation
sets are genotyped on different technologies, predictive
models trained using Illumina 550K SNPs seem to
slightly outperform models using other platforms for the
majority of HLA genes, at both intermediate and high
resolutions. However, the accuracies of prediction at
each HLA gene are generally comparable among the
four genotyping technologies. Detailed accuracy esti-
mates are shown in the Additional file 1: Table S4.
Across Populations
Predictive models, to be useful, should be reproducible
across different study populations of the same ethnicity.
To explore this transferability across populations, we
built predictive models based on samples in the WTCCC
and assessed predictions among Caucasian samples in
the FHCRC cohort, referred to as FHCRC-CEU, shown
in the left panel of Figure 4. The results of the reversed
training and validation populations are shown in the
right panel. The call threshold is set at CT = 0. At inter-
mediate resolutions, prediction accuracies for HLA-A,
-B, -C, and -DQB1 alleles, from WTCCC to FHCRC-
CEU are uniformly around 96%. Even at high resolutions,
prediction accuracies are at least 94%. Conversely, from
FHCRC-CEU to WTCCC, results are quite comparable.
The prediction accuracies for HLA-DRB1 alleles, how-
ever, are somewhat disappointing: they are only 88% at
high resolution in both prediction exercises. This result
may be partially due to the exceptional polymorphism for
HLA-DRB1 allele. Another contributing cause could be
associated with minor errors in existing HLA databases.
Use of Multi-Ethnic Samples in Model Building
The above exercises have shown that our HLA predic-
tive models are generally transferable among
Figure 3 Comparison of cross-platform prediction accuracies among four genotyping arrays. Each square panel shows the accuracies of
HLA predictive models built using SNPs observed and imputed from one genotyping array and validated using SNPs observed and imputed
from another array. The confidence threshold was set at CT = 0.
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Page 8 of 13populations of the same ethnicity. However, the majority
of current large population studies are on Caucasians,
with studies on other ethnic groups being relatively
small or limited. Therefore, predictions of HLA alleles
in studies of non-Caucasian subjects are forced to use
predictive models trained on different ethnic groups,
even though predictions are known to be less accurate.
An interesting question is whether prediction accuracies
will increase if multi-ethnic samples are included in the
training set. To assess this question, we utilized the data
set from the STEP cohort to train the models on Cauca-
sians only (N = 411) and on multi-ethnic groups (N =
450). Figure 5 shows the validation results with CT = 0
on Caucasian samples genotyped on Illumina 1.2M in
WTCCC (left panel), on Mestizo samples who were not
included in the training set (middle panel), and on sam-
ples of other ethnicities in the STEP cohort but were
not included in the training set (right panel). Each panel
lists accuracies across all HLA genes (DPB1 is not avail-
able from WTCCC). To illustrate the prediction accu-
racy of each HLA gene, we used green, dark gray, light
green and light gray bars, corresponding to the four
models resulting from combinations of mixed ethnicity
vs Caucasian and intermediate vs high resolution,
respectively. For Caucasians in WTCCC (left panel), eth-
nic-specific models have better accuracies than the
multi-ethnic models in general. However the reduction
of prediction accuracies of multi-ethnic models is small
at 0.25% and 1.25% at intermediate resolution and high
resolution respectively with CT = 0.
For Mestizos (middle panel) and other ethnicity
groups (right panel), predictive models trained on multi-
ethnic samples perform better than those trained on
samples of different ethnicity (Caucasian in this case)
for all the five HLA loci with CT = 0. For example, for
high resolution HLA-A, the accuracy of prediction
model trained on Caucasians is only 69%, while
improved accuracy of 80% is observed on multi-ethnic
populations. For HLA-B, and -DPB1, the improvement
is quite dramatic, from 38% to 58% and 77% to 97%
respectively. Similar trends have been observed for the
mixture of other ethnic groups. If a higher threshold
such as CT = 0.5 or 0.9 is applied, the multi-ethnic
models still result in greater accuracy, but yield lower
call rates, in general. For details, see Additional file 1:
Table S5. Of course, results should not be over-inter-
preted, given the relatively small sample sizes in both
training and validation sets (see Discussion).
Predictive Models for HLA-A, -B, -C, -DRB1, -DQB1 and -DPB1
Based upon empirical explorations of HLA and SNP
genotype data from three cohorts, we have come to the
following conclusions: 1) use of imputed SNPs is gener-
ally beneficial, 2) predictive models are generalizable
among genotyping technologies and study populations,
and 3) predictive models, built upon multi-ethnic
groups, are preferred, especially for samples without eth-
nic-specific references.
WTCCC  Æ Æ Æ Æ  FHCRC-CEU             FHCRC-CEU Æ Æ Æ Æ WTCCC 
Figure 4 Comparison of prediction accuracies across
populations of the same ethnic group. The accuracies of HLA
predictive models trained on samples from the WTCCC cohort
(genotyped on Affy 500K) and validated on Caucasian samples in
the FHCRC cohort (genotyped on Affy 5.0), and vice versa. Both
observed and imputed HapMap SNPs were applied. The confidence
threshold was set at CT = 0.
Figure 5 Comparison of prediction accuracies between ethnic-
specific model and multi-ethnic model. Building predictive
models using both observed and imputed HapMap SNPs of multi-
ethnicity or Caucasian only samples from the STEP cohort, the
prediction accuracies for Caucasian/Mestizo/other ethnicities are
shown in each panel. The size of the validation set is shown below
each panel. Both the STEP and WTCCC cohort were genotyped on
Illumina 1.2M. The confidence threshold was set at CT = 0.
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we combined all available data sets from the FHCRC,
WTCCC and STEP cohorts to build general predictive
models for HLA-A, -B, -C, -DRB1, -DQB1 and -DPB1.
Resulting models along with the program are available
on our website http://qge.fhcrc.org/MAGprediction/. On
this website, predictive models built using all the Cauca-
sian samples from the FHCRC cohort from our earlier
study [9] are also available. Table 5 lists the characteris-
tics of samples in the final training set. From the
WTCCC cohort, those genotyped on Illumina 1.2M,
a b o u t9 0 %o ft h ee n t i r eW T C C Cc o h o r t ,w e r ei n c l u d e d
in the training set. Table 6 shows counts and positions
of the selected SNPs in the final predictive models, and
Additional file 1: Table S6 lists all selected SNPs for
each HLA locus at both intermediate and high resolu-
tions. For the remaining 10% of WTCCC samples (283
samples) not included in the training set, we treated
them as the validation set, and computed the accuracies
of their predicted HLA alleles (Table 6). As shown,
accuracies of final predicative models approach 99% at
intermediate resolutions and 98% at high resolutions
with CT = 0.
Discussion
In recent years, GWAS of autoimmune diseases have
discovered and validated several SNPs with the MHC
region [16,17]. Some of these autoimmune diseases are
also known to be associated with HLA alleles. To facili-
tate the interpretation of MHC-SNP associations in the
context of HLA without taking on the costly HLA geno-
typing, we propose to use HLA predictive models to
ascertain HLA alleles using their flanking SNPs. The
method we have recently described is capable of achiev-
ing a high level of accuracy in predicting HLA-A, -B,
-C, -DRB1 and -DQB1 at both intermediate ("antigen”)
and high ("allele-level”) resolutions in Caucasians [9]. In
this follow-up study, we have examined several proper-
ties of these predictive models of practical importance
and have reached the following conclusions.
Usefulness of Imputed SNPs
Through explorations of the FHCRC and WTCCC data
sets, we have found that predictive models built with
imputed SNPs usually have greater prediction accura-
cies, and occasionally have lesser accuracies in a negligi-
ble amount. In addition, the use of imputed SNPs
enables the potential of general predictive models
regardless of genotyping technology, which is of great
benefit in terms of increasing sample size and easing the
application of predictive models. Therefore, we conclude
t h a ti m p u t e dS N P s ,b a s e du p o nH a p M a ps a m p l e s ,
should be used for building HLA predictive models.
Genotyping Technologies
Exploring four different genotyping technologies used in
WTCCC, we have found that the concordances of geno-
types between technologies are quite high in general,
except for the case where genotypes are observed from
one technology but are compared with imputed geno-
types with data obtained from a different technology.
Even in this worst case scenario, the concordances are
98.5% or higher. Further, accuracies of prediction for
models built with imputed SNPs, based upon any of
four technologies, are comparable with each other.
Comparing the accuracies trained using genotypes of
one technology and validated using another shows that
the results are generally the best when the training and
validation sets are the same, as expected. When they are
different, Illumina 550K is slightly favored, although dif-
ferences are quite modest. Overall, the prediction
accuracies are comparable and the predictive models are
transferable across genotyping technologies.
Transferability of Predictive Models
The validity of constructed predictive models hinges
upon the local LD, which is influenced by evolutionary
history and related population genetic parameters such
as recombination process and mutations, among HLA
and SNP alleles [9]. Presumably, such LD would be
higher within ethnic groups, and a bit lower between
ethnic groups. Empirical results from our explorations
suggest that predictive models for intermediate resolu-
tion HLA alleles have fairly high accuracies across dif-
ferent study populations of Caucasians. For high
resolution HLA alleles, predictive models for HLA-A, -C
and -DQB1 seem to maintain fairly decent accuracies
across populations. However, for HLA-B and HLA-
DRB1, predictive models seem to have much reduced
accuracies in a different population, probably because
genetic variations in these two loci are much more
recent, negatively impacting their local LD structures.
Given the limited availability of data, we were unable to
evaluate the same question in different ethnic groups.
Table 5 Characteristics of samples in the training set of
the final HLA predictive model
Ethnicity Freq Array Freq HLA- Intermediate
Resolution
High
Resolution
Caucasian 4119 Affy 5.0 1483 A 4027 4025
Mestizo 212 Illumina
1.2M
3279 B 3919 3897
Hispanic 137 C 3674 3648
Black 106 DRB1 4063 4032
Other 188 DQB1 3156 3066
DPB1 832 832
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Page 10 of 13Use of Multi-Ethnic Samples
Our exploration has supported the idea that mixing
multi-ethnic samples into the training set ensures the
presence of more HLA alleles and results in universal
predictive models that tend to perform generally well.
Of course, for situations where many samples, such as
Caucasian samples, are available, ethnic-specific predic-
tive models probably outperform universal models,
although improvements are modest. In conclusion,
unless a large population of the ethnic-specific training
set is available, combining all available ethnic samples as
the training set likely yields preferred predictive models
for most ethnic groups.
While our empirical explorations have yielded sug-
gestive insights to those questions of interest, it is
important to recognize several inherent weaknesses,
which may influence interpretations of our results.
First, due to empirical nature, our conclusions should
be largely restricted to those pertinent populations. To
generalize our observations, it would be desirable to
explore other population-based studies, in particular,
on ethnic groups not being represented here. Second,
sample sizes, especially of ethnic groups other than
Caucasian, are quite small. Given greater genetic diver-
sity in other ethnic groups, especially African, it would
be desirable to expand the current explorations to
those under-studied ethnic populations. Third, HLA
allelic coding in these three studies is not entirely con-
sistent, and genotype quality is also variable, due to
historically different HLA genotyping technologies.
While the best effort has been made to homogenize
HLA alleles, it would be desirable for future efforts to
repeat the model building process with more homoge-
neous HLA data.
Table 7 Prediction accuracies of HLA alleles with frequency exceeding a threshold
Training set Intermediate Resolution High Resolution
HLA- 0.05* 0.03 0 0.05 0.03 0
Caucasians in the FHCRC cohort (N = 1280) A 99 99 98 99 99 97
B9 8 9 7 9 6 9 7 9 7 9 4
C9 7 9 6 9 6 9 7 9 7 9 6
DRB1 97 97 97 91 91 88
DQB1 99 99 99 98 98 98
Caucasians in the STEP cohort (N = 832) A 99 99 95 99 98 95
B9 7 9 7 9 5 9 7 9 7 9 3
C9 6 9 4 9 4 9 5 9 5 9 4
DRB1 98 98 98 98 95 91
* Threshold for HLA allele frequency
The accuracies of HLA predictive models, built with a training set of Caucasian samples from the FHCRC cohort
(genotyped on Affy 5.0) or the STEP cohort (genotyped on Illumina 1.2M), were evaluated using the WTCCC samples
(genotyped on Affy 500K) as the validation set (N = 1480). Only HLA alleles with frequency more than threshold
0.05, 0.03 or 0 in the validation set were evaluated for their prediction accuracies. The confidence threshold was set at CT = 0.
Table 6 Selected SNPs in the final HLA predictive models and their prediction accuracies
Selected SNPs Accuracy%(Call Rate%)
HLA- Count start Stop Length CT = 0 CT = 0.5 CT = 0.9
Intermediate
Resolution
A 33 29,850,894 30,111,284 260,390 98 99(97) 99(89)
B 57 31,267,324 31,554,345 287,021 95 95(99) 96(90)
C 36 31,280,634 31,458,359 177,725 99 99(100) 99(93)
DRB1 33 32,506,503 32,793,404 286,901 98 98(100) 99(81)
DQB1 20 32,444,139 32,778,222 334,083 98 98(100) 99(94)
DPB1 64 33,106,707 33,249,258 142,551 - - -
High
Resolution
A 59 29,918,924 30,171,347 252,423 96 97(95) 97(79)
B 85 31,370,902 31,561,526 190,624 94 95 (95) 96 (81)
C 50 31,187,623 31,444,736 257,113 98 98(99) 98(86)
DRB1 41 32,477,466 32,811,823 334,357 91 94(92) 98(49)
DQB1 28 32,517,462 32,870,439 352,977 98 98(98) 98(92)
DPB1 69 33,093,572 33,290,873 197,301 - - -
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chosen to combine all available samples to build “state
of the art” predictive models for HLA-A, -B, -C, -DRB1,
-DQB1 and -DPB1. For the ease of their applications,
we provide a prediction program which can take SNP
data as input and generate predicted HLA alleles. Pre-
diction accuracies are expected to be quite high for
intermediate and high resolution HLA-A, -B, and -C
alleles among Caucasian samples. However, it is impor-
tant to note that accuracies for common HLA alleles are
generally even higher (Table 7). For example, for HLA-
A high resolution, when the minimum allele frequency
is raised from 0 to 0.05, the prediction accuracy for
WTCCC, of predictive models trained on FHCRC-CEU,
improves from 97% to 99% with CT = 0.
Conclusions
Through empirical explorations, we have demonstrated
that accuracies of predicting HLA alleles using SNPs are
generally above 90% and some are approaching 99%,
depending on HLA loci and resolution. Incorporating
imputed SNPs generally improves prediction accuracies
and enables universal predictive models regardless of
genotyping technology. We also noticed that prediction
accuracies are comparable between different genotyping
technologies and the predictive models are transferable
across genotyping technologies or populations from the
same ethnicity. Although ethnic-specific predictive mod-
els are generally preferred, the empirical data shows that
predictive models built on mixing multi-ethnic samples
also perform well, providing useful predictive models
when ethnic-specific models are not available.
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